


AcuCort Email Formats
Pharmaceutical Manufacturing • Lund, Skåne County, Sweden • 1-10 Employees
AcuCort Email Formats
AcuCort uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@acucort.se), used 66.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@acucort.se | 66.7% |
{first initial}.{last name} | j.doe@acucort.se | 33.3% |
Key Contact at AcuCort
Jonas Jönmark
Chief Executive Officer
Company overview
| Headquarters | Lund, Skåne County, Sweden |
| Phone number | +46465900990 |
| Website | |
| NAICS | 3254 |
| Employees | 1-10 |
| Socials |
About AcuCort
AcuCort has developed and commercializes Zeqmelit™, a new fast-dissolving oral film to put on the tongue, based on the well-known cortisone substance dexamethasone. The drug is a smart product in a new, innovative, patented, and user-friendly dosage form primarily for the treatment of severe and acute allergic reactions, croup in children and chemotherapy-induced nausea and vomiting (CINV) and for the treatment of patients with COVID-19 who need supplemental oxygen therapy. Zeqmelit™ is approved in Sweden, Denmark, and Norway; and AcuCort has signed its first commercial agreement. Altogether, this strengthens the company’s assessment that the time to commercialization may be relatively short. AcuCort (ticker: ACUC) is listed on the Spotlight Stock Market in Sweden. Please visit www.acucort.se.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
AcuCort has 4 employees across 2 departments.
Departments
Number of employees
Funding Data
AcuCort has never raised funding before.
Frequently asked questions
4.8
40,000 users



